Open | - |
Close | - |
Volume / Avg. | 981.000 / 1.048M |
Day Range | - - - |
52 Wk Range | 11.460 - 43.210 |
Market Cap | $1.915B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | % |
Days to Cover | 13.23 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Twist Bioscience (NASDAQ: TWST) through any online brokerage.
Other companies in Twist Bioscience’s space includes: Avidity Biosciences (NASDAQ:RNA), Syndax Pharmaceuticals (NASDAQ:SNDX), TG Therapeutics (NASDAQ:TGTX), PTC Therapeutics (NASDAQ:PTCT) and Protagonist Therapeutics (NASDAQ:PTGX).
The latest price target for Twist Bioscience (NASDAQ: TWST) was reported by Scotiabank on Monday, February 5, 2024. The analyst firm set a price target for 43.00 expecting TWST to rise to within 12 months (a possible 29.83% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Twist Bioscience (NASDAQ: TWST) is $33.12 last updated Today at March 19, 2024 at 8:36 AM EDT.
There are no upcoming dividends for Twist Bioscience.
Twist Bioscience’s Q2 earnings are confirmed for Friday, May 3, 2024.
There is no upcoming split for Twist Bioscience.
Twist Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.